The sale of Ashland's nutraceuticals business could be seen as a positive move, potentially streamlining operations and focusing on core areas. The lack of disclosed terms makes it difficult to assess the financial impact, but divestitures often lead to a reevaluation of company assets and priorities, which can be viewed favorably by investors. The strategic divestiture might also provide Ashland with additional capital for reinvestment or debt reduction.